Foam sclerotherapy of varicose veins;Schaumsklerosierung der varikose

Gefasschirurgie

Volumn 9, Issue 4, 2004, Pages 284-289

  Pannier, F ^a   Rabe, E ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Foam; Polidocanol; Sclerotherapy; Varicose veins

Indexed keywords

SCLEROSING AGENT;

COST EFFECTIVENESS ANALYSIS; ENDOVASCULAR SURGERY; HUMAN; INTERMETHOD COMPARISON; REVIEW; SAPHENOUS VEIN; SCLEROTHERAPY; SIDE EFFECT; VARICOSIS; VEIN SURGERY;

EID: 11144281262     PISSN: 09487034     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00772-004-0368-x     Document Type: Review

References (30)

1. Baccaglini U, Spreafico G, Castoro C, Sorrentino P (1997) Consensus conference on sclerotherapy or varicose veins of the lower limbs. Phlebology 12: 2-16
2. Barrett JM, Allen B, Ockelford A, Goldmann M (2004) Microfoam ultrasound - guided sclerotherapy of varicose veins in 100 legs. Dermatol Surg 30: 6-12
3. Benigni JP, Sadoun S, Thirion V et al. (1999) Télangictasies et varices réticulaires. Traitement par la mousse d'aetoxisclérol - 290
4. Breu FX, Guggenbichler S (2004) European Consensus Meeting on Foam Sclerotherapy, April 4-6 2003, Tegernsee, Germany. Dermatol Surg 30: 709-717
5. Cavezzi A, Frullini A (1998) Il ruola della mousse sclerosante nella ecosclerosi safenica e delle varici recidive. Esperienza personale. Flebologia 9: 1-3
6. Conrad P, Malouf GM, Stacey MC (1995) The Australian polidocanol (aethoxysklerol) study. Results at 2 years. Dermatol Surg 21/4: 334-336
7. Drake LA, Dinehart SM, Goltz RW et al. (1996) Guidelines of care for sclerotherapy treatment of varicose and teleangiectatic leg veins. J Am Acad Dermatol 34: 523-528
8. Dover J, Sadick N, Goldman MP (1999) The role of lasers and light sources in the treatment of leg veins. Derm Surg 25: 328-336
9. Frullini A (2002) Sclerosing foam in the treatment of recurrent varicose veins In: Henriet J P (ed) Foam sclerotherapy state of the art. Editions Phlébologiques Françaises, pp 73-78
10. Frullini A, Cavezzi A (2002) Sclerosing foam in the treatment of varicose veins and teleangiectases: history and analyses of safety and complications. Dermatol Surg 28: 11-15
11. Frullini A (2000) New technique in producing sclerosing faom in a disposable syringe. Dermatol Surg 26: 705-796
12. Hamel-Desnos C, Desnos P, Ouvry P (2003) Nouveautés thérapeutiques dans la prise en charge de la maladie variqueuse: écho-sclérothérapie et mousse. Phlébologie 56/1: 41
13. Hamel-Desnos C, Desnos P, Wollmann JC et al. (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: Initial Results. Dermatol Surg 29: 1170-1175
14. Henriet JP (1997) One year experience with sclerotherapy of reticular veins and telangiectases using polidocanol foam in daily routine: feasibility results, complications. Phlébologie 50/3: 355-360
15. Hohlbaum G (1990) Über iatrogene Schäden bei der Varizensklerosierung. In: Staubesand J, Schöpf E (Hrsg) Neuere Aspekte der Sklerosierungstherapie. Springer, Berlin Heidelberg New York Tokio, S 70-81
16. Kern P, Ramelet AA, Wutschert R, Bounameaux H, Hayoz D (2004) Single-blind, randomized study comparing chromated glycerin, Polidocanol Solution and Polidocanol Foam for Treatment Teleangiectatic leg veins. Dermatol Surg 30: 367-372
17. Kreussler (1996) Aethoxysklerol-Fachinformation der Herstellerfirma, Chemische Fabrik Kreussler & Co GmbH, Stand: 2/1996
18. McCoy S, Evans A, Spurrier N (1999) Sclerotherapy for leg telangiectasia - a blinded comparative trial of polidocanol and hypertonic saline. Dermatol Surg 25: 381-386
19. Monfreux A (1997) Traitement sclérosant des troncs saphèniens et leurs collatérales de gros calibre par la méthode mus. Phlébologie 50/3: 351-353
20. Rabe E (Hrsg) (2003) Grundlagen der Phlebologie, 3. Aufl. Viavital, Köln
21. Rabe E, Pannier-Fischer F, Gerlach H et al. (2003) Leitlinien zur Sklerosierungsbehandlung der Varikose. Phlebologie 32: 101-107
22. Rabe E, Pannier-Fischer F, Gerlach H et al. (2004) Guidelines for sclerotherapy of varicose veins. Dermatol Surg 30: 687-693
23. Sadoun S, Benigni JP (1999) La mousse de sclérosant: état de l'art. In: Rabe E et al. (ed) Phlebology '99. Viavital, Köln, S 146
24. Tessari L, Cavezzi A, Frullini A (2001) Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 27: 58-60
25. Tessari L (2000) Nouvelle technique d'obtention de la sclèro-mousse. Phlébologie 53/1: 129
26. Van Neer PAFA (2004) Perforans varicosis: treatment of incompetent perforating vein is important. Dermatol Surg 30: 754-755
27. Villavicencio J, Pfeifer J, Lohr J et al. (1996) Sclerotherapy for varicose veins: Practice guidelines and sclerotherapy procedures. In: Glovicki P, Yao J (eds) Handbook of venous disorders. Chapmann & Hall Medical, London, pp 337-354
28. Wollmann JC (2002) Schaum - zwischen Vergangenheit und Zukunft. 8. Bonner Venentage 15.-16. Feb. Vasomed 16/1: 34-38
29. Yamaki T, Nozaki M, Fujiwara O, Yoshida E (2002) Duplex-guided foam sclerotherapy for the treatment of the symptomatic venous malformations of the face. Dermatol Surg 28/7: 619-622
30. Yamaki T, Nozaki M, Iwasaka S (2004) Comparative study of duplex-guided foam sclerotherapy and duplex guided liquid sclerotherapy for the treatment of superficial venous insufficiency. Dermatol Surg 30: 718-722